331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster II
0 activities
ADAMTS13 Activity Measurement Using a Chemiluminescence-Based Technique. Prospective Multicenter Comparative Study of the Spanish Apheresis Group (GEA)- Spanish Society of Hematology and Hemotherapy (SEHH)
1 activities
ADAMTS13 Activity Measurement Using a Chemiluminescence-Based Technique. Prospective Multicenter Comparative Study of the Spanish Apheresis Group (GEA)- Spanish Society of Hematology and Hemotherapy (SEHH)
Characterization of Bleeding in Thrombotic Thrombocytopenic Purpura Treated without Caplacizumab
1 activities
Characterization of Bleeding in Thrombotic Thrombocytopenic Purpura Treated without Caplacizumab
Fetal and Maternal Morbidity in Pregnant Patients with Thrombotic Thrombocytopenic Purpura: A Nationwide Analysis
1 activities
Fetal and Maternal Morbidity in Pregnant Patients with Thrombotic Thrombocytopenic Purpura: A Nationwide Analysis
Improving Thrombotic Thrombocytopenic Purpura Outcomes with a TMA Team and TTP Pathway
1 activities
Improving Thrombotic Thrombocytopenic Purpura Outcomes with a TMA Team and TTP Pathway
Leveraging Generative Artificial Intelligence in Diagnosis of Thrombotic Microangiopathies: Focus on Thrombotic Thrombocytopenic Purpura
1 activities
Leveraging Generative Artificial Intelligence in Diagnosis of Thrombotic Microangiopathies: Focus on Thrombotic Thrombocytopenic Purpura
Phase 1, 3-Sequence Interaction Study of Intravenous Vlx-1005 and Argatroban Shows a Favorable Safety, Pharmacokinetic and Pharmacodynamic Profile in Healthy Volunteers
1 activities
Phase 1, 3-Sequence Interaction Study of Intravenous Vlx-1005 and Argatroban Shows a Favorable Safety, Pharmacokinetic and Pharmacodynamic Profile in Healthy Volunteers